Selinexor receives positive opinion from the EMA for the treatment of refractory myelomaAccess, MyelomaJanuary 30, 2021
Watch the webinar “COVID-19 vaccines for myeloma patients: what you need to know.”MPE, Myeloma, VideosApril 30, 2021
Research Grant Application – Shared-Decision Making in MyelomaMPE, Myeloma, Patient evidenceOctober 11, 2021
Listen the voice of myeloma patients in documentary “My myeloma: ready for the steps ahead”MyelomaMarch 22, 2023
EHA 2023 highlights in myeloma and AL amyloidosisAL amyloidosis, Conferences, Myeloma, VideosJune 14, 2023
ASH 2022 | Myeloma and AL amyloidosis updatesAL amyloidosis, Conferences, Myeloma, VideosDecember 12, 2022
EMA recommends conditional marketing authorisation in Europe for teclistamab for relapsed and refractory myelomaAccess, MyelomaJuly 28, 2022
